Dragonfly Therapeutics Announces Sixth Dragonfly TriNKET Opt-in by Bristol Myers Squibb
Since their original 2017 collaboration focusing on hematology malignancies, the companies have agreed to two additional collaborations which include oncology…
56,577$
-0,81%
Echtzeit-Aktienkurs Bristol-Myers Squibb Co.
Bid:
Ask:
Nachrichten zur Bristol-Myers Squibb Co. Aktie
Active Pharmaceutical Ingredient Global Market Report 2023: Featuring Teva Pharmaceutical, Bristol-Myers Squibb, Merck
DUBLIN, Jan. 4, 2023 /PRNewswire/ -- The "Active Pharmaceutical Ingredient Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028:…
XETR : DIVIDEND/INTEREST INFORMATION - 05.01.2023 - US1101221083
Das Instrument BRM US1101221083 BRISTOL-MYERS SQUIBBDL-10 EQUITY wird cum Dividende/Zinsen gehandelt am 04.01.2023 und ex Dividende/Zinsen am 05.01.2023
The instrument BRM…
Will Bristol Myers (BMY) Beat Estimates Again in Its Next Earnings Report?
Bristol Myers (BMY) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients…
Copy_Lotte Biologics completes acqusition of BMS drug plant
Lotte Group has completed a $160 million acquisition of US drug firm Bristol Myers Squibb, the group’s drug manufacturing unit…